Alfred V. Vasconcellos, President & CEO, LCT BioPharma

Al Vasconcellos serves as President and CEO of LCT BioPharma. Prior to LCT, Al was President and CEO of Sertoli Technologies Inc., a Sertoli cell therapy company. As Chief Operating Officer of the ETEX Corporation, he transformed a handful of Harvard scientists into a fully integrated company with domestic and international sales in the field of cell and hard tissue regeneration. Al was a co-founder of CytoTherapeutics Inc., established the Strategic Market Development Department for Pfizer in New York City and headed R&D for the anesthesia and surgical care division of Kendall. He is a medically trained engineer with a business degree from Northwestern University.